![Frédéric Chéreau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Chéreau
Vorstandsvorsitzender bei
SENSORION
Profil
Mr. Frédéric Chéreau is a Chief Executive Officer at Sensorion SA, a Senior VP-Strategy & Business Development at Alexion Pharmaceuticals, Inc., a Chairman at Horama SA, a President, Chief Executive Officer & Director at LogicBio Therapeutics, Inc., a Chairman at Maisons & Cités d'HLM and a Chief Executive Officer at MYOSIX SA. He is on the Board of Directors at LogicBio Therapeutics, Inc. Mr. Chéreau was previously employed as a Member-Supervisory Board by Dynacure SA, a President & Chief Operating Officer by aTyr Pharma, Inc., a Senior Vice President by TRANSKARYOTIC THERAPIES INC, a Senior Vice President-Global Franchise Lead by Shire Pharmaceuticals, Inc., an Executive Chairman by Syndexa Pharmaceuticals Corp., a GM-Cardiovascular Business Unit & VP by Genzyme Corp., and a Chief Operating Officer by MG Biotherapeutics LLC.
He also served on the board at French American Chamber of Commerce New England and Pervasis Therapeutics, Inc. He received his undergraduate degree from Université Paris 1 Panthéon-Sorbonne, a graduate degree from Groupe de Sup de Co La Rochelle and an MBA from INSEAD.
Aktive Positionen von Frédéric Chéreau
| Unternehmen | Position | Beginn |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.04.2016 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.11.2022 |
| SENSORION | Vorstandsvorsitzender | 01.06.2026 |
MYOSIX SA
 MYOSIX SA BiotechnologyHealth Technology Develops cell-based therapeutics | Vorstandsvorsitzender | - |
Horama SA
 Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Vorsitzender | 20.10.2022 |
Maisons & Cités d'HLM
 Maisons & Cités d'HLM Real Estate DevelopmentFinance Engages in renting, buying, selling and managing real estate | Vorsitzender | - |
Ehemalige bekannte Positionen von Frédéric Chéreau
| Unternehmen | Position | Ende |
|---|---|---|
| ATYR PHARMA, INC. | Präsident | 13.07.2015 |
French American Chamber of Commerce New England
 French American Chamber of Commerce New England Miscellaneous Commercial ServicesCommercial Services The French American Chamber of Commerce New England (FACCNE) is a non-profit organization dedicated to fostering French-American business connections in the New England region. The private company is based in Cambridge. It offers membership options that provide benefits, resources, and access to an international business community. The chamber organizes events such as networking opportunities, webinars, workshops, and business forums focused on sectors including life sciences, women in business, HR and leadership, finance, and academia-industry collaboration. Specialized forums include the Women in Business Network, HR & Leadership Development Forum, Life Sciences and Biotechnology, Finance Forum, and Academia & Industry. FACCNE also hosts the annual FAB Awards and provides members with access to the CCIFI Connect mobile app for global networking. The organization supports business development through programs, referral services, and initiatives like learning expeditions and trade missions. | Direktor/Vorstandsmitglied | 01.01.2014 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.12.2013 |
| ░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Frédéric Chéreau
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
86
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Pervasis Therapeutics, Inc.
 Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Produce biologically active vascular technologies | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MYOSIX SA
MYOSIX SA BiotechnologyHealth Technology Develops cell-based therapeutics | Health Technology |
MG Biotherapeutics LLC | |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Syndexa Pharmaceuticals Corp.
 Syndexa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medicines for the treatment and prevention of metabolic diseases | Health Technology |
Maisons & Cités d'HLM
Maisons & Cités d'HLM Real Estate DevelopmentFinance Engages in renting, buying, selling and managing real estate | Finance |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Groupe de Sup de Co La Rochelle
 Groupe de Sup de Co La Rochelle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Health Technology |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
French American Chamber of Commerce New England
French American Chamber of Commerce New England Miscellaneous Commercial ServicesCommercial Services The French American Chamber of Commerce New England (FACCNE) is a non-profit organization dedicated to fostering French-American business connections in the New England region. The private company is based in Cambridge. It offers membership options that provide benefits, resources, and access to an international business community. The chamber organizes events such as networking opportunities, webinars, workshops, and business forums focused on sectors including life sciences, women in business, HR and leadership, finance, and academia-industry collaboration. Specialized forums include the Women in Business Network, HR & Leadership Development Forum, Life Sciences and Biotechnology, Finance Forum, and Academia & Industry. FACCNE also hosts the annual FAB Awards and provides members with access to the CCIFI Connect mobile app for global networking. The organization supports business development through programs, referral services, and initiatives like learning expeditions and trade missions. | Commercial Services |
